Belgium· BE-AMP-SAM379827-00

Idarubicin Sandoz 1 mg/ml

A idarubicin product containing idarubicin hydrochloride, registered in Belgium by Sandoz. The same ATC class is registered in 17 of our 19 countries.

ATC L01DB06

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about idarubicin hydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Idarubicin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01DB06 (idarubicin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search idarubicin products by name

Idarubicin · ATC L01DB06

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Idarubicin Hydrochloride
Manufacturer: Sandoz
Country: Belgium (BE)
ATC code: L01DB06
ATC class: Idarubicin
Defined daily dose: 6 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
0755926
be_apb
2874279

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for idarubicin.

Graded by severity as the source publishes them — 98 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check idarubicin against other medicines How interaction checks work

Idarubicin · interactions on record

435 records

98 severe
328 moderate
9 minor

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Idarubicin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All idarubicin products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Idarubicin Ebewe, Idarubicin Hexal
Bulgaria · Заведос
Cyprus · Zavedos
Czechia · Zavedos
Germany · Idarubicin Hexal, Idarubicin Hikma
Denmark · Zavedos
Spain · Idarubicina Sandoz, Zavedos
Finland · Idarubicin Accord, Zavedos
France · Idarubicine Accord, Zavedos
United Kingdom (Northern Ireland) · Idarubicin Accord Healthcare, Idarubicin Sandoz
Greece · Zacorist, Zavedos
Croatia · Zavedos
Hungary · Zavedos
Ireland · Zavedos
Iceland · Zavedos
Italy · Zavedos
Lithuania · Zavedos
Luxembourg · Zavedos
Latvia · Zavedos
Netherlands · Zavedos
Norway · Zavedos
Poland · Idarubicin Accord, Zavedos
Portugal · Idarrubicina Accord, Idarrubicina Azevedos
Romania · Zavedos
Sweden · Zavedos
Slovenia · Zavedos
Slovakia · Zavedos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/90893396-2204-42de-8919-fd119a47fb73
GET /v1/drugs/90893396-2204-42de-8919-fd119a47fb73?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Idarubicin Sandoz 1 mg/ml",
  "name_fr": "Idarubicin Sandoz 1 mg/ml",
  "name_nl": "Idarubicin Sandoz 1 mg/ml",
  "amp_code": "SAM379827-00",
  "strengths": [
    "1.0000",
    "1.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Idarubicin Hydrochloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Idarubicin",
  "authorisation_numbers": [
    "BE379827"
  ]
}

API reference MCP server Plans

See everything about idarubicin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console